Based on its recent analysis of the biopharmaceutical research tools market, Frost & Sullivan recognizes HP with the 2011 North American Frost & Sullivan New Product Innovation Award for its Digital Dispensing System - hp.com/go/High-PerformanceDispensing. This advanced, high-performance and commercially viable product is set to create new standards in the area of titration of drug compounds.
A unique, stand-alone instrument, the Digital Dispensing System was launched in U.S. and Europe markets in September 2011. It consists of an HP D300 Digital Dispenser, an HP T8 Dispensehead Cassette, and HP Digital Dispensing Software.
"Unlike analog titration, HP's Digital Dispensing System ensures quick, accurate, and error-free results, supporting increased productivity in less time and at a lower cost," notes Frost & Sullivan Industry Manager Jonathan Witonsky. "Developed by repurposing the highly advanced inkjet printing technology, Digital Dispensing System largely simplifies and accelerates the process of drug titration and allows end-users to employ more advanced dose-response strategies than ever before."
As the drug concentrate is directly dispensed into bioassay plates, the system eliminates the intermediate and serial steps, thus significantly reducing manual labor, processing time and delays. For instance, using this system, titrating an entire 96 or 384 microtiter plate can be done within minutes, including the time for setting and programming the instrument.
"The process of digital titration also ensures reliable and accurate results, even when employed for highly advanced and complex experiments," adds Witonsky. "Using the HP Digital Dispensing Software, the end-user can program the most valuable layouts, including complex ones such as randomized layouts or drug combination experiments."
For example, using this system, one compound can be titrated by rows while a second compound can be titrated by columns, thus composing a set of doses. Driven by such simple operations, any biologist can be trained to operate the system efficiently within minutes, whereas conventional titration processes may require days of training for a biologist to be proficient.
"Along with simplifying the entire workflow, it also helps to conserve valuable compounds. Unlike conventional titration processes, HP's Digital Dispensing System reduces unnecessary wastage by up to 90 percent," states Witonsky. "Hence, using HP's Digital Dispensing System can help end-users drastically improve their productivity by efficiently streamlining their drug discovery processes."
The Digital Dispensing System is designed to address the requirements of routine IC50 generation in low/medium-throughput biology labs and extremely advanced and complex drug discovery experiments. For such facilities, HP's Digital Dispensing System is an ideal choice as it helps improve productivity while reducing costs associated with titration time, drug compound material and labor.
"HP has partnered with Tecan to commercialize and distribute this product to the global market," concludes Witonsky. "Through this partnership, HP's high degree of innovation, technological expertise, and product leadership is brought together with Tecan's extensive customer base and market expertise in the biopharmaceutical industry."
In recognition of these features, Frost & Sullivan is proud to present HP with the 2011 New Product Innovation Award in the North American biopharmaceutical research tools market. Each year, Frost & Sullivan presents this award to the company that has demonstrated excellence for the innovative element of its product, for leveraging leading edge technologies in its product and for the product's valued added features/benefits. The awards also lauds the product's potential for increased customer ROI and customer acquisition/penetration.
Frost & Sullivan's Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis and extensive secondary research in order to identify best practices in the industry.
HP creates new possibilities for technology to have a meaningful impact on people, businesses, governments and society. The world's largest technology company, HP brings together a portfolio that spans printing, personal computing, software, services and IT infrastructure at the convergence of the cloud and connectivity, creating seamless, secure, context-aware experiences for a connected world. More information about HP (NYSE: HPQ) is available at hp.com.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 40 offices on six continents.